Compounds > fluorodeoxyglucose f18
Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Facial Hemiatrophy

fluorodeoxyglucose f18 has been researched along with Facial Hemiatrophy in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Burghaus, L; Drzezga, A; Fink, GR; Kobe, C; Rabenstein, M; Uhrhan, K1
Asano, E; Chugani, HT; Fain, D; Juhász, C; Kupsky, WJ; Shah, JR; Sood, S1
Dhawan, V; Eidelberg, D; Fahn, S; Giladi, N; Goldman, S; Hildebrand, J; Przedborski, S; Takikawa, S1

Other Studies

3 other study(ies) available for fluorodeoxyglucose f18 and Facial Hemiatrophy

ArticleYear
Brain Glucose Metabolism in Parry-Romberg Syndrome.
    Clinical nuclear medicine, 2017, Volume: 42, Issue:5

    Topics: Brain; Facial Hemiatrophy; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Young Adult

2017
Rasmussen encephalitis associated with Parry-Romberg syndrome.
    Neurology, 2003, Aug-12, Volume: 61, Issue:3

    Topics: Child; Disease Progression; Encephalitis; Epilepsia Partialis Continua; Facial Hemiatrophy; Fluorodeoxyglucose F18; Frontal Lobe; Gliosis; Humans; Magnetic Resonance Imaging; Male; Parietal Lobe; Tomography, Emission-Computed

2003
Positron emission tomography in hemiparkinsonism-hemiatrophy syndrome.
    Advances in neurology, 1993, Volume: 60

    Topics: Adult; Aged; Atrophy; Blood Glucose; Brain; Deoxyglucose; Dominance, Cerebral; Energy Metabolism; Facial Hemiatrophy; Female; Fluorodeoxyglucose F18; Hemiplegia; Humans; Middle Aged; Neurologic Examination; Parkinson Disease; Tomography, Emission-Computed

1993